Females had significantly (p < 0.05) higher levels of adiponectin, leptin, LAR, and IL-1β, lower levels of ARI, higher proportion of normal blood pressure profile, lower proportion of life-time smokers and normal lipid profile, and were more often taking T2D medications, as compared to males. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.